Pfizer’s ‘Prevnar 20’ gets in FDA fast lane as next-gen pneumococcal vaccine race heats up with Merck
by Angus Liu, Dec 9, 2020 11:53am An application for Pfizer’s 20-valent pneumococcal vaccine candidate, a follow-on to blockbuster shot Prevnar 13,
Read More